20 mg tablet: For the treatment of mild reflux disease and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing).
For long-term management and prevention of relapse in reflux oesophagitis.
Prevention of gastroduodenal ulcers induced by non-selective, non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment.
40 mg tablet: For treatment of duodenal ulcer, gastric ulcer, moderate and severe reflux oesophagitis.